Inari Medical, Inc. (NARI)
Inari Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Irvine, CA, US. The stock last traded at $79.97, up 0.00% on the session, giving a market capitalisation of $4.68B. On trailing twelve-month figures it carries a trailing P/E of -2776.74, a net margin of -0.3%. Its beta of 1.03 implies it has historically moved more than the broad market.
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Inari Medical, Inc. is most often compared with the following Healthcare names: